Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078656599> ?p ?o ?g. }
- W2078656599 endingPage "1882" @default.
- W2078656599 startingPage "1882" @default.
- W2078656599 abstract "<h3>Context</h3>The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) study, which provided optimal medical therapy (OMT) to all patients and demonstrated no incremental advantage of percutaneous coronary intervention (PCI) on outcomes other than angina-related quality of life in stable coronary artery disease (CAD), suggests that a trial of OMT is warranted before PCI. It is unknown to what degree OMT is applied before PCI in routine practice or whether its use increased after the COURAGE trial.<h3>Objective</h3>To examine the use of OMT in patients with stable angina undergoing PCI before and after the publication of the COURAGE trial.<h3>Design, Setting, and Participants</h3>An observational study of patients with stable CAD undergoing PCI in the National Cardiovascular Data Registry between September 1, 2005, and June 30, 2009. Analysis compared use of OMT, both before PCI and at the time of discharge, before and after the publication of the COURAGE trial. Optimal medical therapy was defined as either being prescribed or having a documented contraindication to all medicines (antiplatelet agent, β-blocker, and statin).<h3>Main Outcome Measures</h3>Rates of OMT before PCI and at discharge (following PCI) between the 2 study periods.<h3>Results</h3>Among all 467 211 patients (173 416 before [37.1%] and 293 795 after [62.9%] the COURAGE trial) meeting study criteria, OMT was used in 206 569 patients (44.2%; 95% confidence interval [CI], 44.1%-44.4%) before PCI and in 303 864 patients (65.0%; 95% CI, 64.9%-65.2%) at discharge following PCI (P < .001). Before PCI, OMT was applied in 75 381 patients (43.5%; 95% CI, 43.2%-43.7%) before the COURAGE trial and in 131 188 patients (44.7%; 95% CI, 44.5%-44.8%) after the COURAGE trial (P < .001). The use of OMT at discharge following PCI before and after the COURAGE trial was 63.5% (95% CI, 63.3%-63.7%) and 66.0% (95% CI, 65.8%-66.1%), respectively (P < .001).<h3>Conclusion</h3>Among patients with stable CAD undergoing PCI, less than half were receiving OMT before PCI and approximately two-thirds were receiving OMT at discharge following PCI, with relatively little change in these practice patterns after publication of the COURAGE trial." @default.
- W2078656599 created "2016-06-24" @default.
- W2078656599 creator A5009287612 @default.
- W2078656599 creator A5015021993 @default.
- W2078656599 creator A5015362309 @default.
- W2078656599 creator A5018929273 @default.
- W2078656599 creator A5072232299 @default.
- W2078656599 creator A5089784097 @default.
- W2078656599 date "2011-05-11" @default.
- W2078656599 modified "2023-10-18" @default.
- W2078656599 title "Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention" @default.
- W2078656599 cites W184028435 @default.
- W2078656599 cites W1956394468 @default.
- W2078656599 cites W1970516435 @default.
- W2078656599 cites W1980278232 @default.
- W2078656599 cites W1985088220 @default.
- W2078656599 cites W1986548760 @default.
- W2078656599 cites W1986849025 @default.
- W2078656599 cites W1995977598 @default.
- W2078656599 cites W1998880322 @default.
- W2078656599 cites W2006282324 @default.
- W2078656599 cites W2018606165 @default.
- W2078656599 cites W2021202518 @default.
- W2078656599 cites W2024694491 @default.
- W2078656599 cites W2025090563 @default.
- W2078656599 cites W2034047787 @default.
- W2078656599 cites W2048098319 @default.
- W2078656599 cites W2058435588 @default.
- W2078656599 cites W2064672329 @default.
- W2078656599 cites W2082419761 @default.
- W2078656599 cites W2085533832 @default.
- W2078656599 cites W2086329507 @default.
- W2078656599 cites W2088677484 @default.
- W2078656599 cites W2090506373 @default.
- W2078656599 cites W2111881624 @default.
- W2078656599 cites W2123912984 @default.
- W2078656599 cites W2134422033 @default.
- W2078656599 cites W2136636673 @default.
- W2078656599 cites W2143118485 @default.
- W2078656599 cites W2144407475 @default.
- W2078656599 cites W2147260094 @default.
- W2078656599 cites W2151517168 @default.
- W2078656599 cites W2159999994 @default.
- W2078656599 cites W2160414137 @default.
- W2078656599 cites W2163562470 @default.
- W2078656599 cites W2166351234 @default.
- W2078656599 cites W2167067204 @default.
- W2078656599 cites W2886180054 @default.
- W2078656599 cites W2916392902 @default.
- W2078656599 doi "https://doi.org/10.1001/jama.2011.601" @default.
- W2078656599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21558519" @default.
- W2078656599 hasPublicationYear "2011" @default.
- W2078656599 type Work @default.
- W2078656599 sameAs 2078656599 @default.
- W2078656599 citedByCount "175" @default.
- W2078656599 countsByYear W20786565992012 @default.
- W2078656599 countsByYear W20786565992013 @default.
- W2078656599 countsByYear W20786565992014 @default.
- W2078656599 countsByYear W20786565992015 @default.
- W2078656599 countsByYear W20786565992016 @default.
- W2078656599 countsByYear W20786565992017 @default.
- W2078656599 countsByYear W20786565992018 @default.
- W2078656599 countsByYear W20786565992019 @default.
- W2078656599 countsByYear W20786565992020 @default.
- W2078656599 countsByYear W20786565992021 @default.
- W2078656599 countsByYear W20786565992022 @default.
- W2078656599 countsByYear W20786565992023 @default.
- W2078656599 crossrefType "journal-article" @default.
- W2078656599 hasAuthorship W2078656599A5009287612 @default.
- W2078656599 hasAuthorship W2078656599A5015021993 @default.
- W2078656599 hasAuthorship W2078656599A5015362309 @default.
- W2078656599 hasAuthorship W2078656599A5018929273 @default.
- W2078656599 hasAuthorship W2078656599A5072232299 @default.
- W2078656599 hasAuthorship W2078656599A5089784097 @default.
- W2078656599 hasBestOaLocation W20786565991 @default.
- W2078656599 hasConcept C126322002 @default.
- W2078656599 hasConcept C142724271 @default.
- W2078656599 hasConcept C151730666 @default.
- W2078656599 hasConcept C164705383 @default.
- W2078656599 hasConcept C204787440 @default.
- W2078656599 hasConcept C2776494729 @default.
- W2078656599 hasConcept C2778213512 @default.
- W2078656599 hasConcept C2778425758 @default.
- W2078656599 hasConcept C2779343474 @default.
- W2078656599 hasConcept C2779464278 @default.
- W2078656599 hasConcept C2780400711 @default.
- W2078656599 hasConcept C45393284 @default.
- W2078656599 hasConcept C500558357 @default.
- W2078656599 hasConcept C71924100 @default.
- W2078656599 hasConcept C86803240 @default.
- W2078656599 hasConceptScore W2078656599C126322002 @default.
- W2078656599 hasConceptScore W2078656599C142724271 @default.
- W2078656599 hasConceptScore W2078656599C151730666 @default.
- W2078656599 hasConceptScore W2078656599C164705383 @default.
- W2078656599 hasConceptScore W2078656599C204787440 @default.
- W2078656599 hasConceptScore W2078656599C2776494729 @default.
- W2078656599 hasConceptScore W2078656599C2778213512 @default.
- W2078656599 hasConceptScore W2078656599C2778425758 @default.